Publisher： Bentham Science Publishers
E-ISSN： 1873-4286|19|4|680-686
ISSN： 1381-6128
Source： Current Pharmaceutical Design, Vol.19, Iss.4, 2013-02, pp. : 680-686
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Phosphoinositide 3-kinase signalling - which way to target?
By Wymann M.P. Zvelebil M. Laffargue M.
Trends in Pharmacological Sciences, Vol. 24, Iss. 7, 2003-07 ,pp. :
Access to resources
Recommend
Phosphoinositide 3-kinase α inhibitors: a patent review
Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 7, 2013-07 ,pp. :
Phosphatidylinositol 3-Kinase Isoforms as Novel Drug Targets
Current Drug Targets, Vol. 12, Iss. 7, 2011-06 ,pp. :